Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 9/20 | 0.81 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.70 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | LDHA | P00338 | 1/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
| ▸ | RELA | Q04206 | 1/20 | 0.60 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.58 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30792366 | 1.00 | FFAR1 (0.81) | FFAR1F2RL1NPC1RAB9ALMNA | |
| SCHEMBL1566761 | 0.94 | FFAR1 (0.73) | FFAR1F2RL1NPC1RAB9ALMNA | |
| Anisole SCHEMBL31387002 | 0.94 | FFAR1 (0.74) | FFAR1F2RL1NPC1RAB9AFFAR4 | |
| SCHEMBL4898458 | 0.91 | FFAR1 (0.69) | FFAR1F2RL1NPC1RAB9ALMNA | |
| Anisole SCHEMBL30496784 | 0.91 | FFAR1 (0.70) | FFAR1F2RL1NPC1RAB9AFFAR4 | |
| SCHEMBL5702383 | 0.90 | FFAR1 (0.68) | FFAR1F2RL1NPC1RAB9ALMNA | |
| SCHEMBL5250063 | 0.90 | FFAR1 (1.00) | FFAR1F2RL1NPC1RAB9ALMNA | |
| SCHEMBL503646 | 0.89 | ALOX5 (0.68) | FFAR1F2RL1FFAR4ALDH1A1 | |
| SCHEMBL6439322 | 0.88 | FFAR1 (0.66) | FFAR1F2RL1NPC1RAB9ALMNA | |
| SCHEMBL4898363 | 0.87 | FFAR1 (0.64) | FFAR1F2RL1NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036668-A | Alpha, beta unsaturated ketone substituted chromone derivative and medicinal use thereof | 中国药科大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122036772-A | Synthesis method of beta-pinacol borate-alkyl ketone compound | 陇东学院 | 2026-05-15 | — | — | CN | claimed |
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| EP-4444108-B1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| EP-3164107-B1 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | TAKASAGO PERFUMERY CO LTD (JP) | 2025-09-03 | — | — | EP | claimed |
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2025-05-20 | — | — | US | claimed |
| WO-2025026525-A1 | HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS | SYMRISE AG (DE) | 2025-02-06 | — | — | WO | claimed |
| EP-4469439-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-12-04 | — | — | EP | claimed |
| EP-3689324-B1 | NEW COOLING AGENTS AND PREPARATIONS COMPRISING THEM | SYMRISE AG (DE) | 2024-11-20 | — | — | EP | claimed |
| EP-4428219-A2 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2024-09-11 | — | — | EP | claimed |
| EP-0661932-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1995-07-12 | — | — | EP | claimed |
| EP-0414550-B1 | A salt substitute granule | BRITISH TECH GROUP USA (US) | 1995-03-15 | — | — | EP | claimed |
| WO-1993010677-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0485587-A4 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS | — | 1992-12-02 | — | — | EP | claimed |
| EP-0485587-A1 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS. | BIORESEARCH INC (US) | 1992-05-20 | — | — | EP | claimed |
| US-5094862-A | Sugar coated with sodium chloride | WARNER-LAMBERT COMPANY (US) | 1992-03-10 | — | — | US | claimed |
| WO-1991018523-A1 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS | BIORESEARCH, INC. (US) | 1991-12-12 | — | — | WO | claimed |
| US-5021249-A | Nonsweet carbohydrate bulking agents, coated with a reduced amount of flavoring | WARNER-LAMBERT COMPANY (US) | 1991-06-04 | — | — | US | claimed |
| EP-0414550-A2 | A salt substitute granule | BRITISH TECHNOLOGY GROUP USA INC. (US) | 1991-02-27 | — | — | EP | claimed |
| EP-0351973-A2 | Savoury flavoured nonsweet compositions using sweet carbohydrate bulking agents and processes for their preparation | WARNER-LAMBERT COMPANY (US) | 1990-01-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | HSD11B1, HSD11B2, HSD17B1 | FFAR1 623/4885F2RL1 2070/4885NPC1 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.